Your browser doesn't support javascript.
The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE Heart Failure Care network.
Cowie, Martin R; Mourilhe-Rocha, Ricardo; Chang, Hung-Yu; Volterrani, Maurizio; Ban, Ha Ngoc; Campos de Albuquerque, Denilson; Chung, Edward; Fonseca, Cândida; Lopatin, Yuri; Magaña Serrano, José Antonio; Mircheva, Lilyana; Moncada-Paz, Gustavo Adolfo; Pagava, Zurab; Reyes, Eugenio B; Saldarriaga, Clara; Schwartzmann, Pedro; Sim Kheng Leng, David; Trivi, Marcelo; Yotov, Yoto Trifonov; Zieroth, Shelley.
  • Cowie MR; Royal Brompton Hospital, Guy's & St Thomas' NHS Foundation Trust, and School of Cardiovascular Medicine and Sciences, Faculty of Lifesciences & Medicine, King's College London, London, UK. Electronic address: martin.cowie@kcl.ac.uk.
  • Mourilhe-Rocha R; Pedro Ernesto University Hospital, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil; Hospital Pró-Cardíaco, Rio de Janeiro, RJ, Brazil.
  • Chang HY; Heart Center, Cheng Hsin General Hospital, and Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Volterrani M; Department of Cardiovascular and Respiratory Sciences, Scientific Institute for Research, Hospitalization and Health Care (IRCCS) San Raffaele Roma, Rome, Italy.
  • Ban HN; Ho Chi Minh City Heart Institute, Ho Chi Minh City, Viet Nam.
  • Campos de Albuquerque D; Pedro Ernesto University Hospital, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil.
  • Chung E; Department of Medicine, University of the West Indies, Mona, Jamaica.
  • Fonseca C; Heart Failure Clinic, Department of Internal Medicine, São Francisco Xavier Hospital, and NOVA Medical School, Faculty of Medical Sciences, NOVA University, Lisbon, Portugal.
  • Lopatin Y; Regional Cardiology Centre, Volgograd State Medical University, Volgograd, Russian Federation.
  • Magaña Serrano JA; Division of Heart Failure and Cardiac Transplantation, Cardiology Hospital, National Medical Center "Siglo XXI", Mexican Social Security Institute, Mexico City, Mexico.
  • Mircheva L; Second Cardiology Clinic, University Hospital St. Marina, and First Department of Internal Medicine, Medical University of Varna, Varna, Bulgaria.
  • Moncada-Paz GA; Department of Cardiology, Honduran Social Security Institute, and Faculty of Medical Sciences, National Autonomous University of Honduras, Tegucigalpa, Honduras.
  • Pagava Z; Bokhua Memorial Cardiovascular Center, Tbilisi, Georgia.
  • Reyes EB; Philippine General Hospital and Division of Cardiovascular Medicine, University of the Philippines, Manila, Philippines.
  • Saldarriaga C; Department of Cardiology, Pontifical Bolivarian University and University of Antioquia, Medellín, Colombia.
  • Schwartzmann P; Unimed Hospital Ribeirão Preto and Advanced Center for Research, Teaching and Diagnosis, Ribeirão Preto, SP, Brazil.
  • Sim Kheng Leng D; Department of Cardiology, National Heart Centre Singapore, Singapore.
  • Trivi M; Department of Clinical Cardiology, Buenos Aires Cardiovascular Institute, Buenos Aires, Argentina.
  • Yotov YT; Second Cardiology Clinic, University Hospital St. Marina, and First Department of Internal Medicine, Medical University of Varna, Varna, Bulgaria.
  • Zieroth S; Heart Failure and Transplant Clinics, St. Boniface Hospital, and Section of Cardiology, University of Manitoba, Winnipeg, MB, Canada.
Int J Cardiol ; 363: 240-246, 2022 09 15.
Article in English | MEDLINE | ID: covidwho-1907111
ABSTRACT
During the COVID-19 pandemic, reductions in heart failure (HF) hospitalizations have been widely reported, and there is an urgent need to understand how HF care has been reorganized in countries with different infection levels, vaccination rates and healthcare services. The OPTIMIZE Heart Failure Care program has a global network of investigators in 42 countries, with first-hand experience of the impact of the pandemic on HF management in different care settings. The national coordinators were surveyed to assess 1) the challenges of the COVID-19 pandemic for continuity of HF care, from both a hospital and patient perspective; 2) the organizational changes enacted to ensure continued HF care; and 3) lessons learned for the future of HF care. Contributions were obtained from 37 national coordinators in 29 countries. We summarize their input, highlighting the issues raised and using the example of three very different settings (Italy, Brazil, and Taiwan) to illustrate the similarities and differences across the OPTIMIZE program.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Failure Type of study: Diagnostic study / Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Int J Cardiol Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Failure Type of study: Diagnostic study / Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Int J Cardiol Year: 2022 Document Type: Article